Company intelligence / Profile preview

Suzhou Sanray Pharmaceutical

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Suzhou Sanray Pharmaceutical is a clinical-stage biopharmaceutical company based in Suzhou, China, that integrates drug discovery services with internal therapeutic development. Originally established as a specialist in Drug Metabolism and Pharmacokinetics (DMPK), the company has utilized its technical expertise to build a pipeline of innovative small molecule drugs. Their research focus primarily covers oncology and metabolic disorders, with lead candidates targeting CDK4/6 and the GLP-1 receptor. Sanray continues to operate as a high-end CRO while advancing its proprietary programs through clinical trials in both China and international markets.

Therapeutic areas: OncologyEndocrinologyRheumatologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Suzhou Sanray Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suzhou Sanray Pharmaceutical.

Explore the full profile